# Stellus Capital Investment Corp: financial statements, quarterly

SCM · NYSE · CIK 1551901 · [Other](/sectors/other.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/scm.md) · [Financials](/companies/scm/financials.md) · [Filings](/companies/scm/filings.md) · [Insiders](/companies/scm/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/scm/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [8.0](/filings/0001558370-23-018035.md) | [8.0 d](/filings/0001558370-24-002368.md) | [7.8](/filings/0001558370-24-007593.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.3](/filings/0001558370-24-014910.md) | [0.3 d](/filings/0001104659-26-026432.md) | [0.4](/filings/0001558370-25-007374.md) | [0.6](/filings/0001558370-25-010509.md) | [0.4](/filings/0001104659-25-109139.md) | [0.5 d](/filings/0001104659-26-026432.md) | [0.5](/filings/0001104659-26-058699.md) | [0.4](/filings/0001104659-26-093435.md) | [0.5](/filings/0001104659-25-109139.md) | [0.1 d](/filings/0001104659-26-026432.md) | [0.4](/filings/0001104659-26-058699.md) | [0.0](/filings/0001104659-26-093435.md) |
| Net income | $m | [(2.4)](/filings/0001558370-24-014910.md) | [11.5 d](/filings/0001104659-26-026432.md) | [13.1](/filings/0001558370-25-007374.md) | [8.5](/filings/0001558370-25-010509.md) | [15.5](/filings/0001104659-25-109139.md) | [8.7 d](/filings/0001104659-26-026432.md) | [5.0](/filings/0001104659-26-058699.md) | [10.1](/filings/0001104659-26-093435.md) | [6.7](/filings/0001104659-25-109139.md) | [5.2 d](/filings/0001104659-26-026432.md) | [1.7](/filings/0001104659-26-058699.md) | [16.2](/filings/0001104659-26-093435.md) |
| Diluted EPS | $ per share | [(0.11)](/filings/0001558370-24-014910.md) | not reported | [0.54](/filings/0001558370-25-007374.md) | [0.35](/filings/0001558370-25-010509.md) | [0.59](/filings/0001104659-25-109139.md) | not reported | [0.18](/filings/0001104659-26-058699.md) | [0.36](/filings/0001104659-26-093435.md) | [0.23](/filings/0001104659-25-109139.md) | not reported | [0.06](/filings/0001104659-26-058699.md) | [0.56](/filings/0001104659-26-093435.md) |
| Basic EPS | $ per share | [(0.11)](/filings/0001558370-24-014910.md) | not reported | [0.54](/filings/0001558370-25-007374.md) | [0.35](/filings/0001558370-25-010509.md) | [0.59](/filings/0001104659-25-109139.md) | not reported | [0.18](/filings/0001104659-26-058699.md) | [0.36](/filings/0001104659-26-093435.md) | [0.23](/filings/0001104659-25-109139.md) | not reported | [0.06](/filings/0001104659-26-058699.md) | [0.56](/filings/0001104659-26-093435.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [19.2](/filings/0001558370-23-018035.md) | [26.1](/filings/0001558370-25-002182.md) | [48.8](/filings/0001558370-24-007593.md) | [35.9](/filings/0001558370-24-011352.md) | [38.6](/filings/0001558370-24-014910.md) | [20.1](/filings/0001104659-26-026432.md) | [10.9](/filings/0001558370-25-007374.md) | [40.0](/filings/0001558370-25-010509.md) | [9.0](/filings/0001104659-25-109139.md) | [25.1](/filings/0001104659-26-093435.md) | [3.4](/filings/0001104659-26-058699.md) | [5.1](/filings/0001104659-26-093435.md) |
| Total assets | $m | [912](/filings/0001558370-23-018035.md) | [908](/filings/0001558370-25-002182.md) | [935](/filings/0001558370-24-007593.md) | [947](/filings/0001558370-24-011352.md) | [957](/filings/0001558370-24-014910.md) | [981](/filings/0001104659-26-026432.md) | [1,012](/filings/0001558370-25-007374.md) | [1,035](/filings/0001558370-25-010509.md) | [1,029](/filings/0001104659-25-109139.md) | [1,041](/filings/0001104659-26-093435.md) | [1,001](/filings/0001104659-26-058699.md) | [982](/filings/0001104659-26-093435.md) |
| Total liabilities | $m | [594](/filings/0001558370-23-018035.md) | [588](/filings/0001558370-25-002182.md) | [612](/filings/0001558370-24-007593.md) | [599](/filings/0001558370-24-011352.md) | [591](/filings/0001558370-24-014910.md) | [611](/filings/0001104659-26-026432.md) | [639](/filings/0001558370-25-007374.md) | [659](/filings/0001558370-25-010509.md) | [651](/filings/0001104659-25-109139.md) | [670](/filings/0001104659-26-093435.md) | [638](/filings/0001104659-26-058699.md) | [615](/filings/0001104659-26-093435.md) |
| Shareholders' equity | $m | [318](/filings/0001558370-23-018035.md) | [320](/filings/0001558370-25-002182.md) | [323](/filings/0001558370-24-007593.md) | [347](/filings/0001558370-24-011352.md) | [366](/filings/0001558370-24-014910.md) | [370](/filings/0001104659-26-026432.md) | [373](/filings/0001558370-25-007374.md) | [375](/filings/0001558370-25-010509.md) | [378](/filings/0001104659-25-109139.md) | [371](/filings/0001104659-26-093435.md) | [363](/filings/0001104659-26-058699.md) | [367](/filings/0001104659-26-093435.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(10.5) d](/filings/0001558370-24-014910.md) | [25.2 d](/filings/0001104659-26-026432.md) | [4.5](/filings/0001558370-25-007374.md) | [(13.1) d](/filings/0001558370-25-010509.md) | [11.8 d](/filings/0001104659-25-109139.md) | [(31.8) d](/filings/0001104659-26-026432.md) | [(36.9)](/filings/0001104659-26-058699.md) | [23.7 d](/filings/0001104659-26-093435.md) | [(20.2) d](/filings/0001104659-25-109139.md) | [9.0 d](/filings/0001104659-26-026432.md) | [22.8](/filings/0001104659-26-058699.md) | [33.4 d](/filings/0001104659-26-093435.md) |
| Dividends paid | $m | [9.1 d](/filings/0001558370-24-014910.md) | [12.9 d](/filings/0001104659-26-026432.md) | [6.4](/filings/0001558370-25-007374.md) | [9.8 d](/filings/0001558370-25-010509.md) | [10.5 d](/filings/0001104659-25-109139.md) | [10.8 d](/filings/0001104659-26-026432.md) | [11.0](/filings/0001104659-26-058699.md) | [11.3 d](/filings/0001104659-26-093435.md) | [11.4 d](/filings/0001104659-25-109139.md) | [11.6 d](/filings/0001104659-26-026432.md) | [10.4](/filings/0001104659-26-058699.md) | [9.8 d](/filings/0001104659-26-093435.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | Q2 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [19.5](/filings/0001558370-23-018035.md) | [19.8](/filings/0001558370-24-007593.md) | [21.2](/filings/0001558370-24-011352.md) | [22.8](/filings/0001558370-24-014910.md) | [24.1](/filings/0001558370-25-007374.md) | [24.7](/filings/0001558370-25-010509.md) | [26.3](/filings/0001104659-25-109139.md) | [27.6](/filings/0001104659-26-058699.md) | [28.4](/filings/0001104659-26-093435.md) | [28.5](/filings/0001104659-25-109139.md) | [28.9](/filings/0001104659-26-058699.md) | [28.9](/filings/0001104659-26-093435.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 28,479,937 at 2026-08-10, from the cover of the [10-Q filed 2026-08-10](/filings/0001104659-26-093435.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.